fda compounding semaglutide crackdown news today π¨ Moves to Shut Down Mass-Market Compounded GLP-1s The FDA is taking action to restrict widely marketed, nonβFDA-approved compounded GLP-1 products, citing concerns over safety, quality, and misleading claims. As demand FDA proposes a new GLP-1
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours Β· Estimated delivery Aug 26 - Aug 31

























